Arch Therapeutics, Inc.

0.1608

0.0000

Volume:- -

Turnover:- -

Market Cap:714.66K

PE:-0.07

High:0.1608

Open:0.1608

Low:0.1608

Close:0.1608

52wk High:0.8400

52wk Low:0.1573

Shares:4.44M

Float Shares:4.30M

Volume Ratio:0.03

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3462

EPS(LYR):-2.2715

ROE:-4014.80%

ROA:-199.27%

PB:-0.06

PE(LYR):-0.07

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Arch Therapeutics Inc. Files for Chapter 11 Bankruptcy; Court Approves Asset Sale Bidding Procedures and Stalking Horse Bid

Reuters

·

May 24

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ARTH"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTH\",,,,,undefined,":{"symbol":"ARTH","market":"US","secType":"STK","nameCN":"Arch Therapeutics, Inc.","latestPrice":0.1608,"timestamp":1756497600000,"preClose":0.1608,"halted":0,"volume":0,"delay":15,"floatShares":4297158,"shares":4444400,"eps":-2.346175,"marketStatus":"Closed Labor Day","change":0,"latestTime":"08-29 16:00:00 EDT Delay","open":0.1608,"high":0.1608,"low":0.1608,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-2.346175,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1756800000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.1608,"volumeRatio":0.028958359685171516},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTH\",,,,,undefined,":{"symbol":"ARTH","floatShares":4297158,"roa":"-199.27%","roe":"-4014.80%","lyrEps":-2.271494,"volumeRatio":0.028958359685171516,"shares":4444400,"dividePrice":0,"high":0.1608,"amplitude":0,"preClose":0.1608,"low":0.1608,"week52Low":0.1573,"pbRate":"-0.06","psRate":"4.82","week52High":0.84,"institutionHeld":0,"latestPrice":0.1608,"eps":-2.346175,"divideRate":0,"volume":0,"delay":15,"ttmEps":-2.346175,"open":0.1608,"prevYearClose":0.17,"prevWeekClose":0.1608,"prevMonthClose":0.1608,"prevQuarterClose":0.1608,"fiveDayClose":0.1608,"twentyDayClose":0.1608,"sixtyDayClose":0.1608},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-19","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1724040000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-09","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-02-20","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1708405200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-08-11","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1691726400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-01-18","symbol":"ARTH","defaultRemindTime":1674052200000,"type":"split","dateTimestamp":1674018000000,"forFactor":200,"toFactor":1,"ratio":200}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARTH\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537152463","title":"Arch Therapeutics Inc. Files for Chapter 11 Bankruptcy; Court Approves Asset Sale Bidding Procedures and Stalking Horse Bid","url":"https://stock-news.laohu8.com/highlight/detail?id=2537152463","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537152463?lang=en_us&edition=fundamental","pubTime":"2025-05-24 04:41","pubTimestamp":1748032866,"startTime":"0","endTime":"0","summary":"Arch Therapeutics, Inc. has initiated bankruptcy proceedings under Chapter 11, filing voluntary petitions alongside its subsidiary, Arch Biosurgery, Inc., in the United States Bankruptcy Court for the District of Massachusetts. The company continues operations as a debtor-in-possession and has accepted a stalking horse bid for the sale of substantially all its assets, with the possibility of higher offers. A hearing to approve the asset sale is scheduled for June 20, 2025. The bankruptcy proceedings may lead to the cancellation of all equity securities without any recovery to shareholders. The court has authorized Arch Therapeutics to secure postpetition financing and use cash collateral, granting liens and superpriority administrative expense status. The company aims to confirm a Chapter 11 plan of liquidation, including a Section 363 sale of its assets free of liens and claims, within seven weeks. Vivex Biologics, Inc. has been designated as the stalking horse bidder, with a credit b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL7WnTk8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","ARTHQ","ARTH"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ARTH\",params:#limit:6,delay:false,,,undefined,":[]}}